- Filed
- May 20, 2024 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2024 · May 15, 2024 | 4.22M sh |
| Cash And Equivalents | Q1 2024 · Mar 31, 2024 | $141K |
| Cash And Equivalents | Q1 2024 · Dec 31, 2023 | $176K |
| Stockholders Equity | Q1 2024 · Mar 31, 2024 | −$2.21M |
| Stockholders Equity | Q1 2024 · Dec 31, 2023 | −$2.28M |
| Total Liabilities | Q1 2024 · Mar 31, 2024 | $2.97M |
| Total Liabilities | Q1 2024 · Dec 31, 2023 | $3.13M |
| Current Assets | Q1 2024 · Mar 31, 2024 | $880K |
| Current Assets | Q1 2024 · Dec 31, 2023 | $1.14M |
| Total Assets | Q1 2024 · Mar 31, 2024 | $1.25M |
| Total Assets | Q1 2024 · Dec 31, 2023 | $1.41M |
| Shares Diluted | Q1 2024 · Mar 31, 2023 | 4.22M sh |
| Capex | Q1 2024 · Mar 31, 2023 | $26K |
| Operating Cash Flow | Q1 2024 · Mar 31, 2023 | −$417K |
| Eps Diluted | Q1 2024 · Mar 31, 2023 | −$0.04 |
| Eps Basic | Q1 2024 · Mar 31, 2023 | −$0.04 |
| Sga Expense | Q1 2024 · Mar 31, 2023 | $160K |
| Rd Expense | Q1 2024 · Mar 31, 2023 | $233K |
| Net Income | Q1 2024 · Mar 31, 2023 | −$186K |
| Operating Income | Q1 2024 · Mar 31, 2023 | −$393K |